<code id='0FA23459EB'></code><style id='0FA23459EB'></style>
    • <acronym id='0FA23459EB'></acronym>
      <center id='0FA23459EB'><center id='0FA23459EB'><tfoot id='0FA23459EB'></tfoot></center><abbr id='0FA23459EB'><dir id='0FA23459EB'><tfoot id='0FA23459EB'></tfoot><noframes id='0FA23459EB'>

    • <optgroup id='0FA23459EB'><strike id='0FA23459EB'><sup id='0FA23459EB'></sup></strike><code id='0FA23459EB'></code></optgroup>
        1. <b id='0FA23459EB'><label id='0FA23459EB'><select id='0FA23459EB'><dt id='0FA23459EB'><span id='0FA23459EB'></span></dt></select></label></b><u id='0FA23459EB'></u>
          <i id='0FA23459EB'><strike id='0FA23459EB'><tt id='0FA23459EB'><pre id='0FA23459EB'></pre></tt></strike></i>

          
          WSS
          Mayo Clinic, in Rochester, Minnesota on
          Photo by KEREM YUCEL/AFP via Getty Images

          SAN FRANCISCO — Mayo Clinic has signed Silicon Valley tech startup Cerebras as its first generative AI partner, the health system announced Monday.

          The health system — known for its cutting-edge research and willingness to partner with tech companies — will give Cerebras millions of dollars to help build technology tools based on Mayo’s trove of de-identified patient data, leaders announced at the J.P. Morgan Healthcare Conference. Mayo and Cerebras did not disclose the dollar amount, but Cerebras said it was a multimillion, multi-year contract.

          advertisement

          With roughly 380 employees, Cerebras builds and sells supercomputers specifically designed for AI applications across several industries — pitting the upstart in direct competition with the market leader Nvidia Corp. Life sciences giants including GSK have used its technology for drug discovery, and it has partnered with a health network in United Arab Emirates, but this is Cerebras’ first AI contract with a U.S. health system. The deal gives Mayo access to Cerebras’ supercomputers as well as a Cerebras team to help develop health-tuned models; Mayo will then own whatever they build.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Leave your comment

          Please enter your name
          Please enter your comment

          knowledge